These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32835083)

  • 1. Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors.
    Balmeh N; Mahmoudi S; Mohammadi N; Karabedianhajiabadi A
    Inform Med Unlocked; 2020; 20():100407. PubMed ID: 32835083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
    Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
    Wicik Z; Eyileten C; Jakubik D; Simões SN; Martins DC; Pavão R; Siller-Matula JM; Postula M
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
    Li C; Wang R; Wu A; Yuan T; Song K; Bai Y; Liu X
    BMC Med Genomics; 2022 Apr; 15(Suppl 2):94. PubMed ID: 35461273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.
    Ahmed JQ; Maulud SQ; Dhawan M; Priyanka ; Choudhary OP; Jalal PJ; Ali RK; Tayib GA; Hasan DA
    J Infect Public Health; 2022 Jul; 15(7):788-799. PubMed ID: 35751930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
    Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
    Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mutated antimicrobial peptides to inhibit ACE2, TMPRSS2 and GRP78 receptors of SARS-CoV-2 and angiotensin II type 1 receptor (AT1R) as well as controlling COVID-19 disease.
    Abedi Dorcheh F; Balmeh N; Hejazi SH; Allahyari Fard N
    J Biomol Struct Dyn; 2023 Dec; ():1-24. PubMed ID: 38109185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
    Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
    Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
    J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern.
    Capistrano KJ; Richner J; Schwartz J; Mukherjee SK; Shukla D; Naqvi AR
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166612. PubMed ID: 36481486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
    Li C; Hu X; Li L; Li JH
    J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.
    Eyileten C; Wicik Z; Simões SN; Martins-Jr DC; Klos K; Wlodarczyk W; Assinger A; Soldacki D; Chcialowski A; Siller-Matula JM; Postula M
    RNA Biol; 2022 Jan; 19(1):963-979. PubMed ID: 35938548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients.
    Mortazavi F; Soltanshahi M; Tamaddon G
    Iran J Pharm Res; 2023; 22(1):e137832. PubMed ID: 38444707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
    Chen Z; Wang X; Li L; Han M; Wang M; Li Z; Xie X; Du H; Xie Z; Zhang H
    Microb Pathog; 2021 Sep; 158():105051. PubMed ID: 34153417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
    Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
    Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.
    Bozgeyik I
    Meta Gene; 2021 Feb; 27():100831. PubMed ID: 33224734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.